This charge allows Dove to recover its editorial and production costs and to create a pool of funds that can be used to provide fee waivers for authors from lesser developed countries.

[5] Dove is a member of the Association of Learned and Professional Society Publishers, the Committee on Publication Ethics, and the Open Archives Initiative.

[10] Dove Medical Press is a privately held company founded in 2003[11] by Tim Hill, a former managing director of Adis International and five other founders.

In 2013, the Dove Medical Press journal Drug Design, Development and Therapy accepted a false and intentionally flawed paper created and submitted by an investigative journalist for Science as part of a "sting" to test the effectiveness of the peer-review processes of open access journals (Who's Afraid of Peer Review?).

[13] After satisfying The Open Access Scholarly Publishers Association Membership Committee that new editorial and peer review procedures were in place to address the concerns raised during its investigation, Dove Medical Press was reinstated as a full member of Open Access Scholarly Publishers Association in September 2015.